The R&D Process

ZEUS Scientific develops new and improved technologies to better diagnose patients

ZEUS Scientific's R&D team has developed over 155 test kits that are available to the global market, numerous new assays currently in clinical development, and several being evaluated by the various regulatory agencies to bring to market. Our activities are focused on applying the latest technologies to discover and develop potential new assays with the goal of maintaining the position as global leader in diagnostic innovation.

All R&D and manufacturing is done at the ZEUS Scientific headquarters in Branchburg, New Jersey under strict quality and regulatory guidelines. The researchers at ZEUS are highly qualified and trained professionals with extensive backgrounds and talents that continue to drive innovative products and technologies to the global market. Our R&D laboratories are the home to 14 scientists with over 175 years of combined experience.

The R&D team at ZEUS consists of scientists and technicians dedicated to different areas of our R&D process, including:

• Clinical development – to handle clinical studies of new products, as well as regulatory submissions
• Molecular diagnostics – to develop innovations in this cutting-edge diagnostic arena
• Product development – to examine the needs of the healthcare community and explore ways to facilitate diagnoses through innovative products

Our long time experience with global regulatory agencies as a manufacturer of medical diagnostic kits provides a practical approach to domestic as well as international regulatory compliance.

ZEUS Scientific is held to the highest of quality standards on a worldwide basis, we conform to all applicable regulatory and international standards for in vitro diagnostic device manufacturers, most notably:

• The Food and Drug Administration (FDA) Code of Federal Regulation 21 CFR 820
• International Organization for Standardization ISO 13485:2003 Standard
• 98/79 EC Directive